PAFAH1B3 and sarcoma: OS, DSS, and PFI analysis of various cancer types showed that increased PAFAH1B3 expression correlated with poor overall survival for ACC, LIHC, LUAD, mesothelioma (MESO), sarcoma (SARC), and SKCM (Figure 2A), and poor DSS in BLCA, SARC, LIHC, LUAD, MESO, and SKCM (Figure 2B).